Comparative effect of Curcuma longa and Emblica Officinalis on kidney function test (KFT) of Diabetic mice

Authors

  • Pramod Shanker   TGT (Science), S.R.P.S. Govt. Sr. Sec. School, Gardanibagh, Patna, Bihar, India

Keywords:

Antidiabetic, Emblica Officinalis, Curcuma longa, Streptozotocin, Kidney Function Test.

Abstract

Diabetes mellitus in the present date has become a major health concern problem in the population worldwide. The drugs available for the medication are very limited and have side effects hence new drug discovery is required. The present study is aimed to investigate the anti- diabetic and antitoxic effects of Emblica officinalis (Amla) fruit extract and curcuma longa(Turmeric)rhizome extract on Streptozotocin induced diabetic mice.

The study was approved through the Institutional Animal Ethics Committee of the institute. Mice were grouped into 3 groups – Control (n=6), Streptozotocin treated (n=6) and Emblica officinalis administered group (n=6).and momordica, charantia administered group(n=6). Treated group mice were administered with Streptozotocin 100 mg/kg body weight intraperitoneally. After the development of diabetes in mice the aqueous fruit, extract of Emblica officinalis at the rate of 100 mg/kg body weight and rhizome extract curcuma longa(Turmeric)@ 200mg/kg body weight  was administered for 4 weeks to evaluate its anti- hyperglycemic activity. There serum glucose levels as well as the Kidney Function Tests (KFT) – urea, uric acid and creatinine levels were analyzed statistically using ANOVA and Dunnett’s tests. In the present study, there was significant increase in the serum glucose levels in the Streptozotocin induced diabetic group in comparison to control group while in the Emblica officinalis and curcuma longa group there was significant decrease in the glucose denotes the antidiabetic effect. The KFT showed significant elevation in the levels in Streptozotocin induced groups while the Emblica officinalis and curcuma longa showed significant decrease in in the KFT levels denotes the antitoxic effects. Thus, from the entire study it can be concluded that Emblica officinalis and curcuma longa can be used as a more potent natural anti-diabetic drug than curcuma longa, which can control the diabetes at much extent. Furthermore, it also prevents the kidney from the diabetic damage and restores of cellular status of the kidney.

References

  1. Nain P, Saini V, Sharma S, Nain J (2012) Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. Leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J Ethnopharmacol 142: 65-71.
  2. Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
  3. Baynes JW (1995) Reactive oxygen in the etiology and complications of diabetes. In: Ioannides, C., Flatt, P.R. (Eds.), Drug, Diet and Disease: Mechanistic Approach to Diabetes, Ellis Horwood Limited, Hertfordshire 2: 203-231.
  4. Zhang YJ, Tanaka T, Iwamoto Y, Yang CR, Kouno I (2000) Novel norsesquiterpenoids from the roots of Phyllanthus emblica. J Nat Prod 63: 1507-1510.
  5. Kim HJ, Yokozawa T, Kim HY, Tohda C, Rao TP, et al. (2005) Influence of amla (Emblica officinalis gaertn) on hypercholesterolemia and lipid peroxidation in cholesterol- fed rats. J Nutr Sci Vitaminol 51: 413-418.
  6. Georg P, Ludvik B (2000) Lipids and Diabetes. J Clin Basic Cardiol 3: 159-162.
  7. ADA (American Diabetes Association) (2004) Hypertension management in adults with diabetes (Position Statement). Diabetes Care 27: S65-S67.
  8. Ueda Y, Akiyama M, Ohta K, Miyaji T (2003) cosmological evolution of the hard x-ray active galactic nucleus luminosity function and the origin of the hard x-ray background. Apj 598: 886.
  9. Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, et al. (2004) Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 292: 2227-2236.
  10. Dioka CE, OE Orisakwe, FAAdeniyi, SC Meludu (2004) Liver and renal function tests in artisans occupationally exposed to lead in mechanic village in Nnewi, Nigeria. Int J Environ Res Pub Hlth 1: 21-25.
  11. Kalia K, SJS Flora (2005) Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning. J Occup Hlth 47: 11-21.
  12. Hink HU, N Santanam, S Dikalov (2002) Peroxidase properties of extracellular superoxide dismutase: Role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol 22: 1402-1408.
  13. Ames BN, R Cathcart, E Schwiers, P Hochst (1981) Uric acid provides an antioxidant defence against and radical caused aging and cancer: A hypotheis Proc Natl Acad Sci 78: 6858-6862.
  14. Dabla PK (2010) Renal function in diabetic nephropathy. World J Diabetes 1: 48-56.
  15. Bonventre JV (2012) Can we target tubular damage to prevent renal function decline in diabetes? Semin Nephrol 32: 452-462.
  16. Jack M, D Wright (2012) Role of advanced glycation end products and glyoxalase I in diabetic peripheral sensory neuropathy. Transl Res 159: 355-365.
  17. Kumar NP, AR Annamalai, RS Thakur (2009) Antinociceptive property of Emblica officinalis Gaertn (Amla) in high fat diet- fed/low dose streptozotocin induced diabetic neuropathy in rats. Indian J Exp Biol 47: 737-742.
  18. Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK (1999) Antioxidant activity of active tannoid principles of Emblica officinalis (amla) Indian. J Exp Biol 37: 676-680.
  19. D'souza JJ, D'souza PP, Fazal F, Kumar A, Bhat HP, et al. (2014) Anti-diabetic effects of the Indian indigenous fruit Emblica officinalis Gaertn: active constituents and modes of action. Food Funct 5: 635-644.
  20. Punithavathi VR, PS Prince, R Kumar, J Selvakumari (2011) Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. Eur J Pharmacol 650: 465-471.
  21. Punithavathi VR, P Stanely Mainzen Prince, MR Kumar, CJ Selvakumari (2011) Protective effects of gallic acid on hepatic laipid peroxide metabolism, glycoprotein components and lipids in streptozotocin-induced type II diabetic Wistar rats. J Biochem Mol Toxicol 25: 68-76.
  22. Sabu MC, R Kuttan (2002) Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 81: 155-160.
  23. Qureshi SA, W Asad, V Sultana (2009) The Effect of Phyllantus emblica Linn on Type-II Diabetes, Triglycerides and Liver- Specie Enzyme, Pak. J Nutr 8: 125-128.
  24. Tirgar PR, KV Shah, D Rathod, TR Desai, RK Goyal (2011) Investigation Into Mechanism of Action of Anti-Diabetic Activity of Emblica officinalis on Streptozotocin Induced Type I Diabetic Rat. Pharmacology online 2: 556-575.
  25. ADA (American Diabetes Association) (2009) Standards of Medical Care in Diabetes. Diabetes Care 32: S13-S61.
  26. WHO Guideline: sugars intake in adults and children (2015) Geneva: World Health Organization.
  27. Andrew JK (2000) Diabetes, Churchill living stone, New York, 2000.

International Journal of Scientific Research in Science, Engineering and Technology

Downloads

Published

2018-02-25

Issue

Volume 4, Issue 6, January-February-2018

Section

Research Articles

License

Copyright (c) IJSRSET

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Pramod Shanker , " Comparative effect of Curcuma longa and Emblica Officinalis on kidney function test (KFT) of Diabetic mice, International Journal of Scientific Research in Science, Engineering and Technology(IJSRSET), Print ISSN : 2395-1990, Online ISSN : 2394-4099, Volume 4, Issue 6, pp.344-350, January-February-2018.